Kyle Gano

Insider Reports History

Location
San Diego, CA
Signature
/s/ Darin Lippoldt, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kyle Gano:

Stock Role Class Num Shares Value Price $ Report Date Ownership
NEUROCRINE BIOSCIENCES INC Chief Executive Officer, Director Common Stock 140K $19.9M $141.97 04 Nov 2025 Direct
NEUROCRINE BIOSCIENCES INC Chief Executive Officer, Director Restricted Stock Unit 1.84K $785K $116.72 01 Nov 2025 Direct
NEUROCRINE BIOSCIENCES INC Chief Executive Officer, Director Incentive Stock Option 0 $0 $43.24 15 Jan 2025 Direct
NEUROCRINE BIOSCIENCES INC Chief Executive Officer, Director Non-Qualified Stock Option 0 $0 $73.60 15 Jan 2025 Direct
NEUROCRINE BIOSCIENCES INC Chief Executive Officer, Director Stock Option 105K 12 Feb 2025 Direct

Insider Reports Filed by Kyle Gano

Symbol Company Period Transactions Value $ Form Type Role Filing Time
NBIX NEUROCRINE BIOSCIENCES INC 01 Nov 2025 3 -$42.6K 4 Chief Executive Officer, Director 04 Nov 2025, 20:18
NBIX NEUROCRINE BIOSCIENCES INC 12 Feb 2025 8 -$299K 4 Chief Executive Officer, Director 14 Feb 2025, 18:20
NBIX NEUROCRINE BIOSCIENCES INC 08 Feb 2025 3 -$116K 4 Chief Executive Officer, Director 12 Feb 2025, 18:48
NBIX NEUROCRINE BIOSCIENCES INC 31 Jan 2025 3 -$236K 4 Chief Executive Officer, Director 04 Feb 2025, 17:47
NBIX NEUROCRINE BIOSCIENCES INC 15 Jan 2025 6 -$7.05M 4 Chief Executive Officer, Director 17 Jan 2025, 16:32
NBIX NEUROCRINE BIOSCIENCES INC 01 Nov 2024 2 $0 4 Chief Executive Officer, Director 01 Nov 2024, 19:52
NBIX NEUROCRINE BIOSCIENCES INC 13 Feb 2024 3 -$180K 4 Chief Business Development Off 15 Feb 2024, 17:40
NBIX NEUROCRINE BIOSCIENCES INC 06 Feb 2024 2 -$359K 4 Chief Business Development Off 08 Feb 2024, 19:17
NBIX NEUROCRINE BIOSCIENCES INC 31 Jan 2024 1 -$217K 4 Chief Business Development Off 02 Feb 2024, 19:17
NBIX NEUROCRINE BIOSCIENCES INC 02 Jan 2024 6 -$9.86M 4 Chief Business Development Off 04 Jan 2024, 18:32
NBIX NEUROCRINE BIOSCIENCES INC 21 Aug 2023 1 -$229K 4 Chief Business Development Off 23 Aug 2023, 21:05
NBIX NEUROCRINE BIOSCIENCES INC 13 Feb 2023 2 $0 4 Chief Business Development Off 15 Feb 2023, 18:10
NBIX NEUROCRINE BIOSCIENCES INC 06 Feb 2023 4 -$1.75M 4 Chief Business Development Off 08 Feb 2023, 18:25
NBIX NEUROCRINE BIOSCIENCES INC 31 Jan 2023 1 -$169K 4 Chief Business Development Off 02 Feb 2023, 16:15
NBIX NEUROCRINE BIOSCIENCES INC 07 Feb 2022 5 -$555K 4 Chief Business Development Off 09 Feb 2022, 17:58
NBIX NEUROCRINE BIOSCIENCES INC 31 Jan 2022 2 $0 4 Chief Business Development Off 02 Feb 2022, 19:02
NBIX NEUROCRINE BIOSCIENCES INC 05 Jan 2022 3 -$2.42M 4 Chief Business Development Off 07 Jan 2022, 17:04